Research output

Research output per year 1984 2006 2009 2012 2015 2016 2017 2024

• 378 Article
• 67 Review article
• 51 Letter
• 20 Editorial
• 33 More
  • 15 Chapter
  • 12 Comment/debate
  • 6 Short survey

Research output per year

Research output per year

Search results

• 2024

  Apolipoproteins and the risk of giant cell arteritis—a nested case–control study

  Wadström, K., Jacobsson, L. T. H., Mohammad, A. J., Warrington, K. J., Matteson, E. L. & Turesson, C., Dec 2024, In: Arthritis Research and Therapy. 26, 1, 37.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Giant Cell Arteritis 100%
  • Apolipoproteins 91%
  • Giant Cells 82%
  • Apolipoprotein A-I 35%
  • Apolipoproteins B 25%

• Decline in Incidence of Extra-Articular Manifestations of Rheumatoid Arthritis: A Population-Based Cohort Study

  Kimbrough, B. A., Crowson, C. S., Davis, J. M., Matteson, E. L. & Myasoedova, E., Apr 2024, In: Arthritis Care and Research. 76, 4, p. 454-462 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Rheumatoid Arthritis 100%
  • Joints 85%
  • Cohort Studies 82%
  • Incidence 58%
  • Confidence Intervals 57%
• 2023

  Analyses of plasma inflammatory proteins reveal biomarkers predictive of subsequent development of giant cell arteritis: a prospective study

  Wadström, K., Jacobsson, L. T. H., Mohammad, A. J., Warrington, K. J., Matteson, E. L., Jakobsson, M. E. & Turesson, C., Jun 1 2023, In: Rheumatology (United Kingdom). 62, 6, p. 2304-2311 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Giant Cell Arteritis 100%
  • Blood Proteins 68%
  • Biomarkers 50%
  • Prospective Studies 49%
  • Odds Ratio 37%

• Lower Frequency of Comorbidities Prior to Onset of Giant Cell Arteritis: A Population-Based Study

  Elfishawi, M., Rakholiya, J., Gunderson, T. M., Achenbach, S. J., Crowson, C. S., Matteson, E. L., Turesson, C., Wadström, K., Weyand, C., Koster, M. J. & Warrington, K. J., 2023, In: Journal of Rheumatology. 50, 4, p. 526-531 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Giant Cell Arteritis 100%
  • Comorbidity 60%
  • Incidence 32%
  • Population 30%
  • Diabetes Mellitus 22%

• Rheumatoid Vasculitis

  Makol, A., Kermani, T., Warrington, K., Stone, J. H. & Matteson, E. L., Jan 1 2023, A Clinician's Pearls and Myths in Rheumatology: Second Edition. Springer International Publishing, p. 25-35 11 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Rheumatoid Vasculitis 94%
  • Cyclophosphamide 79%
  • Protective 46%
  • Vasculitis 29%
  • Biopsy 28%

• Thromboangiitis Obliterans

  Makol, A., Cooper, L. T., Stone, J. H. & Matteson, E. L., Jan 1 2023, A Clinician's Pearls and Myths in Rheumatology: Second Edition. Springer International Publishing, p. 473-479 7 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Thromboangiitis Obliterans 100%
  • Disorder 56%
  • Extremities 49%
  • Veins 36%
  • Ischemia 33%
• 2022

  Association Between Payments by Pharmaceutical Manufacturers and Prescribing Behavior in Rheumatology

  Duarte-García, A., Crowson, C. S., McCoy, R. G., Herrin, J., Lam, V., Putman, M. S., Ross, J. S., Matteson, E. L. & Shah, N. D., Feb 2022, In: Mayo Clinic proceedings. 97, 2, p. 250-260 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Rheumatology 100%
  • Medicare 74%
  • Rheumatologists 50%
  • Food and Beverages 40%
  • Pharmaceutical Preparations 38%

• Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study

  Koster, M. J., Crowson, C. S., Giblon, R. E., Jaquith, J. M., Duarte-García, A., Matteson, E. L., Weyand, C. M. & Warrington, K. J., 2022, In: Annals of the rheumatic diseases. 81, 6, p. 861-867 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • baricitinib 100%
  • Giant Cell Arteritis 71%
  • Glucocorticoid 70%
  • Prednisone 42%
  • Antimicrobial Agent 38%

• Canonical and noncanonical regulatory roles for JAK2 in the pathogenesis of rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis

  Wang, S., Liu, M., Li, X., Zhang, J., Wang, F., Zhang, C., Roden, A., Ryu, J. H., Warrington, K. J., Sun, J., Matteson, E. L., Tschumperlin, D. J. & Vassallo, R., Jun 2022, In: FASEB Journal. 36, 6, e22336.

  Research output: Contribution to journal › Article › peer-review

  • Idiopathic Pulmonary Fibrosis 100%
  • Interstitial Lung Diseases 91%
  • Interstitial 86%
  • Rheumatoid Arthritis 68%
  • Signal Transduction 25%

• Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data

  Duong, S. Q., Crowson, C. S., Athreya, A., Atkinson, E. J., Davis, J. M., Warrington, K. J., Matteson, E. L., Weinshilboum, R., Wang, L. & Myasoedova, E., Dec 2022, In: Arthritis Research and Therapy. 24, 1, 162.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Machine Learning 100%
  • Blood Sedimentation 98%
  • Methotrexate 85%
  • Rheumatoid Arthritis 73%
  • Joints 62%

• Dr. Berti et al reply

  Berti, A., Cornec, D., Crowson, C. S. & Matteson, E. L., Feb 1 2022, In: Journal of Rheumatology. 49, 2, p. 234 1 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Noncanonical JAK1/STAT3 interactions with TGF-β modulate myofibroblast transdifferentiation and fibrosis

  Wang, F., Wang, S., Zhang, C., Tian, X., Zhou, Y., Xuan, W., Matteson, E. L., Luo, F., Tschumperlin, D. & Vassallo, R., Dec 2022, In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 323, 6, p. L698-L714

  Research output: Contribution to journal › Article › peer-review

  • Myofibroblasts 100%
  • Transforming Growth Factor beta 79%
  • Fibrosis 64%
  • Fibroblasts 64%
  • Lung 46%

• Outpatient healthcare utilization among incident cases of systemic sclerosis: results from a population-based US cohort (1988–2016)

  Coffey, C. M., Sandhu, A. S., Crowson, C. S., Asante, D., Matteson, E. L., Osborn, T. G., Warrington, K. J. & Makol, A., 2022, In: Scandinavian Journal of Rheumatology. 51, 4, p. 323-328 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Systemic Scleroderma 100%
  • Outpatients 66%
  • Delivery of Health Care 53%
  • Population 34%
  • Sclerosis 23%

• Response to: 'Increasing incidence of autoantibody-negative RA is replicated and is partly explained by an aging population' by Matthijssen et al

  Myasoedova, E., Davis, J., Matteson, E. L. & Crowson, C. S., May 1 2022, In: Annals of the rheumatic diseases. 81, 5, p. E70

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Risk of Sudden Death in a General Unbiased Epidemiological Cohort of Sarcoidosis

  Chahal, C. A. A., Brady, P. A., Cooper, L. T., Lin, G., Somers, V. K., Crowson, C. S., Matteson, E. L. & Ungprasert, P., Aug 16 2022, In: Journal of the American Heart Association. 11, 16, e025479.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Sarcoidosis 100%
  • Sudden Death 95%
  • Sudden Cardiac Death 89%
  • Population 15%
  • Incidence 9%

• Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics-Driven Machine Learning Approach

  Pharmacogenetics of Methotrexate in Rheumatoid Arthritis Consortium, Jun 2022, In: Arthritis Care and Research. 74, 6, p. 879-888 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pharmacogenetics 100%
  • Machine Learning 99%
  • Methotrexate 85%
  • Rheumatoid Arthritis 72%
  • Supervised Machine Learning 46%
• 2021

  A novel humanized model of rheumatoid arthritis associated lung disease

  Lin, L., Xuan, W., Luckey, D., Wang, S., Wang, F. P., Lau, J., Warrington, K. J., Matteson, E. L., Vassallo, R. & Taneja, V., Sep 2021, In: Clinical Immunology. 230, 108813.

  Research output: Contribution to journal › Article › peer-review

  • Lung Diseases 100%
  • Rheumatoid Arthritis 92%
  • Arthritis 58%
  • Bleomycin 50%
  • Emphysema 50%

• Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes

  Monti, S., Craven, A., Klersy, C., Montecucco, C., Caporali, R., Watts, R., Merkel, P. A., Luqmani, R., Achilleos, K., Adler, M., Alba, M. A., Albert, D. A., Alibaz-Oner, F., Allcoat, P., Amano, K., Amarasuriya, M., Amudala, N. A., Andrews, J., Archer, A. M., Arimura, Y., & 376 othersAtukorala, I., Azevedo, E., Bajad, S., Baldwin, C., Barra, L. J., Baslund, B., Basu, N., Baykal, M., Berger, C., Berglin, E., Besada, E., Bhardwaj, M., Bischof, A., Blockmans, D., Blood, J., Draibe, J. B., Brand, S., Brandao, M., Bruce, I. N., Butler, A., Calabrese, L. H., Ferrer, D. C., Carette, S., Carmona, D., Ceunen, H., Chakravarty, K., Chapman, P. T., Chocova, Z., Chung, S. A., Ci, W., Cid, M. C., Clark, T. M., Clarkson, M. R., De Jesus Contreras-Rodríguez, F., Conway, R., Cooke, K., Virós, X. C., Cordeiro, A., Costa, A., Craven, A., Culfear, K., Daikeler, T., Danda, D., Das, S. K., Dasgupta, B., De Castro, A. M., Dehghan, N., Devassy, R., Dhindsa, N., Diamantopoulos, A. P., Direskeneli, H., Dobashi, H., Juan, D., Durrani, M., Edelsten, C., Eifert, J., Elhayek, S., Elsideeg, S., Endo, T., Erden, A., Erer, B., Eriksson, P., Erturk, Z., Espígol-Frigolé, G., Felicetti, M., Ferraro, A., Ferro, J. M., Fifi-Mah, A., Flores-Suárez, L. F., Flossmann, O., Flynn, D., Fonseca, J. E., Foot, J., Foote, M., Forbess, L., Fujimoto, S., Fukuoka, K., Furtado, C., Furuta, S., Gaffo, A. L., Gallagher, P., Gao, N., Gatenby, P., Gendi, N., Geraldes, R., Gerits, A., Gioffredi, A., Gomples, L., Goncąlves, M. J., Gondo, P., Graham, A., Grainger, R., Gray, D. T., Grayson, P. C., Griffiths, L., Guo, Y., Gupta, R., Gylling, M., Hajj-Ali, R. A., Hammam, N., Harigai, M., Hartley, L., Haslett, J., Hassan, A., Hatemi, G., Hellmich, B., Henckaerts, L., Henes, J. C., Hepburn, J., Herd, V., Hess, C., Hill, C., Hinojosa-Azaola, A., Hirahashi, J., Hirano, F., Hočevar, A., Holle, J., Hollinger, N., Homma, S., Howard, T., Hoyles, R. K., Hruskova, Z., Hutcheon, G., Ignacak, M., Igney-Oertel, A., Ikeda, K., Ikegaya, N., Jagadeesh, S., Jaquith, J., Jayne, D. R. W., Jewell, T., Jones, C., Joshi, A., Kalyoncu, U., Kamall, S., Kamath, S., Lai, K. S., Kaname, S., Kanchinadham, S., Karadaǧ, Ö., Karube, M., Kaszuba, M., Kaur, R., Kawakami, T., Kawashima, S., Khalidi, N., Khan, A., Kikuchi, M., Kilic, L., Kimura, M., King, M. J., Klapa, S., Klocke, R., Kobayashi, T., Kobayashi, S., Komagata, Y., Kronbichler, A., Kuczia, P., Kumar, M. S., Kurosawa, M., Lamprecht, P., Langford, C. A., Lanyon, P., Laversuch, C., Lee, S. J., Leoni, S., Li, J., Liang, K., Liang, P., Liao, H., Lee, L. A., Luqmani, R. A., Lyle, A., Macdonald, M., Mackie, S. L., Madden, L., Magliano, M., Makino, H., Makol, A., Malaiya, R., Malaviya, A., Manthri, R., Maritati, F., Da Silva, A. M., Mason, J. C., Matara, C., Matsui, K., Matteson, E. L., Mcbride, D., Mccullough, K., Mcgeoch, L., Mclaren, J., Mcmillian, C., Mendiratta, N., Menon, A., Merinopoulos, D., Merkel, P. A., Merkel, P., Messier, S., Micheletti, R. G., Mills, K., Milman, N., Minoda, M., Minz, R. W., Möck, C., Mohammad, A. J., Moiseev, S., Moitinho, M., Molloy, E., Monach, P. A., Montgomery, M., Moosig, F., Moradizadeh, M., Morgan, M., Morgan, A. W., Morgan, A. M., Muir, A., Mukhtyar, C., Müller, A., Muratore, F., Muso, E., Nada, R., Nakajima, H., Nakajima, T., Nakano, H., Nandagudi, A., Neumann, T., Ng, Y. F., Ng, K. H., Nogueira, E. L., Nolkha, N., Nordström, D., Novikov, P., Nugaliyadde, A., O'donnell, J. L., O'donoghue, J., O'neill, L., O'riordan, E., Oatley, M., Okubo, K., Oliva, E., Oshikawa, H., Ota, Y., Padoan, R., Pagnoux, C., Pan, L., Panaritis, K., Park, J. K., Patel, S., Patil, P., Pazzola, G., Peall, A., Pearce, F., Pehlevan, S., Pereira, L., Pettersson, T., Pineau, C. A., Pirilä, L., Poglodek, B., Ponte, C., Prieto-González, S., Priya, S. R., Purewal, B., Purschke, S., Putaala, J., Quickert, S., Quincey, V., Raghuvanshi, S., Rajasekhar, L., Ranganathan, D., Rathi, M., Rees, D., Rees, F., Renken, U., Restuccia, G., Rhee, R. L., Rice, B., Robins, D., Robson, J., Rodrigues, M., Romaõ, V. C., Rotar, C., Ruediger, C., Rutgers, A., Sá, A. C., Saavedra, M. J., Sada, K. E., Sahbudin, I., Salvarani, C., Sandhu, N., Santos, E., Sato, Y., Schäfer, V. S., Schiavon, F., Schmidt, W. A., Segelmark, M., Shahin, A., Sharma, A., Shotton, J., Silva, C., Singer, O. G., Sivasuthan, G., Smolen, S., Solanich-Moreno, X., Boixader, L. S., Song, Y. W., Springer, J., Sreih, A. G., Srivastava, R., Stamp, L. K., Stevens, R., Strbian, D., Sugino, K., Sunderkötter, C., Suppiah, R., Suzuki, K., Suzuki, K., Szekanecz, Z., Sznajd, J., Taimen, K., Tak, P. P., Takeuchi, T., Takizawa, N., Tames, L., Tan, B. E., Tanaka, M., Tang, M. W., Tatlisumak, T., Tesar, V., Thomas, A., Tian, X., Tokunaga, K., Tombetti, E., Tomšič, M., Toz, B., Tsukamoto, T., Uchida, S., Unal, A. U., Urban, M. L., Usui, J., Vaglio, A., Venkatachalam, S., Vermaak, E., Viswanath, V., Wada, T., Wagh, S., Wallace, D. J., Walters, G., Walz, B., Wan, J., Wang, T., Wang, G., Warrington, K. J., Watts, R. A., Wawrzycka-Adamczyk, K., Weeratunga, P., Weisman, M. H., Wickramasinghe, S., Williams, M., Williams, M., Wojcik, K., Woodruff, L., Xenitidis, T., Yamada, H., Yamagata, K., Yee, C. S., Yoon, M., Yoshida, K., Yoshifuji, H., Ytterberg, S. R., Yumura, W., Zayed, H., Zeng, X., Zhao, M. H., Zugaj, A. & Zuk, J., Feb 1 2021, In: Rheumatology (United Kingdom). 60, 2, p. 617-628 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 100%
  • Age of Onset 65%
  • Systemic Vasculitis 29%
  • Age Groups 16%
  • Mortality 11%

• Comment on: Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis: Reply

  Wadström, K., Jacobsson, L., Mohammad, A. J., Warrington, K. J., Matteson, E. L. & Turesson, C., Jul 1 2021, In: Rheumatology (United Kingdom). 60, 7, p. E262-E263

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Dr. Elfishawi, et al reply

  Elfishawi, M. M., Crowson, C. S., Matteson, E. L. & Bongartz, T., Mar 1 2021, In: Journal of Rheumatology. 48, 3, p. 468 1 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Epidemiology and trends in survival of systemic sclerosis in Olmsted County (1980–2018): A population-based study

  Coffey, C. M., Radwan, Y. A., Sandhu, A. S., Crowson, C. S., Bauer, P. R., Matteson, E. L. & Makol, A., Oct 2021, In: Journal of Scleroderma and Related Disorders. 6, 3, p. 264-270 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Systemic Scleroderma 100%
  • Epidemiology 68%
  • Survival 48%
  • Population 34%
  • Rheumatic Diseases 26%

• Erectile dysfunction and cardiovascular risk in men with rheumatoid arthritis: A population-based cohort study

  Wilton, K. M., Achenbach, S. J., Davis, J. M., Myasoedova, E., Matteson, E. L. & Crowson, C. S., Nov 1 2021, In: Journal of Rheumatology. 48, 11, p. 1641-1647 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Erectile Dysfunction 100%
  • Rheumatoid Arthritis 77%
  • Cohort Studies 63%
  • Population 36%
  • Peripheral Arterial Disease 17%

• Erectile dysfunction in men with psoriatic arthritis: A population-based cohort study

  Wilton, K. M., Achenbach, S. J., Karmacharya, P., Ernste, F. C., Matteson, E. L. & Crowson, C. S., Apr 1 2021, In: Journal of Rheumatology. 48, 4, p. 527-532 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Psoriatic Arthritis 100%
  • Erectile Dysfunction 88%
  • Cohort Studies 56%
  • Population 32%
  • Incidence 6%

• Hospitalization rates are highest in the first 5 years of systemic sclerosis: Results from a population-based cohort (1980-2016)

  Coffey, C. M., Sandhu, A. S., Crowson, C. S., Achenbach, S. J., Matteson, E. L., Osborn, T. G., Warrington, K. J. & Makol, A., Jun 1 2021, In: Journal of Rheumatology. 48, 6, p. 877-882 6 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Systemic Scleroderma 100%
  • Hospitalization 64%
  • Population 34%
  • Length of Stay 13%
  • Sclerosis 9%

• IL-23 amplifies the epithelial-mesenchymal transition of mechanically conditioned alveolar epithelial cells in rheumatoid arthritis-associated interstitial lung disease through mTOR/S6 signaling

  Zhang, C., Wang, S., Lau, J., Roden, A. C., Matteson, E. L., Sun, J., Luo, F., Tschumperlin, D. J. & Vassallo, R., Dec 2021, In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 321, 6, p. L1006-L1022

  Research output: Contribution to journal › Article › peer-review

  • Ribosomal Protein S6 100%
  • Interleukin-23 85%
  • Alveolar Epithelial Cells 75%
  • TOR Serine-Threonine Kinases 74%
  • Interstitial Lung Diseases 73%

• Increased risk of valvular heart disease in systemic sclerosis: An underrecognized cardiac complication

  Kurmann, R. D., Am, E. A. E., Radwan, Y. A., Sandhu, A. S., Crowson, C. S., Matteson, E. L., Warrington, K. J., Mankad, R. & Makol, A., Jul 1 2021, In: Journal of Rheumatology. 48, 7, p. 1047-1052 6 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Heart Valve Diseases 100%
  • Systemic Scleroderma 91%
  • Sclerosis 46%
  • Incidence 11%
  • Tricuspid Valve Insufficiency 7%

• Methotrexate and rheumatoid arthritis associated interstitial lung disease

  Juge, P. A., Lee, J. S., Lau, J., Kawano-Dourado, L., Serrano, J. R., Sebastiani, M., Koduri, G., Matteson, E., Bonfiglioli, K., Sawamura, M., Kairalla, R., Cavagna, L., Cassione, E. B., Manfredi, A., Mejia, M., Rodríguez-Henriquez, P., González-Pérez, M. I., Falfán-Valencia, R., Buendia-Roldán, I., Pérez-Rubio, G., & 35 othersEbstein, E., Gazal, S., Borie, R., Ottaviani, S., Kannengiesser, C., Wallaert, B. T., Uzunhan, Y., Nunes, H., Valeyre, D., Saidenberg-Kermanac h, N., Boissier, M. C., Wemeau-Stervinou, L., Flipo, R. M., Marchand-Adam, S., Richette, P., Allanore, Y., Dromer, C., Truchetet, M. E., Richez, C., Schaeverbeke, T., Lioté, H., Thabut, G., Deane, K. D., Solomon, J. J., Doyle, T., Ryu, J. H., Rosas, I., Michael Holers, V., Boileau, C., Debray, M. P., Porcher, R., Schwartz, D. A., Vassallo, R., Crestani, B. & Dieudé, P., Feb 1 2021, In: European Respiratory Journal. 57, 2, 2000337.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Interstitial Lung Diseases 100%
  • Methotrexate 88%
  • Rheumatoid Arthritis 75%
  • Case-Control Studies 5%
  • Meta-Analysis 4%
  13 Scopus citations

• Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process

  Roofeh, D., Barratt, S. L., Wells, A. U., Kawano-Dourado, L., Tashkin, D., Strand, V., Seibold, J., Proudman, S., Brown, K. K., Dellaripa, P. F., Doyle, T., Leonard, T., Matteson, E. L., Oddis, C. V., Solomon, J. J., Sparks, J. A., Vassallo, R., Maxwell, L., Beaton, D., Christensen, R., & 2 othersTownsend, W. & Khanna, D., Dec 2021, In: Seminars in Arthritis and Rheumatism. 51, 6, p. 1331-1341 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Connective Tissue Diseases 100%
  • Systemic Scleroderma 94%
  • Interstitial Lung Diseases 91%
  • Vital Capacity 79%
  • Systematic Reviews 61%

• Systemic sclerosis portends increased risk of conduction and rhythm abnormalities at diagnosis and during disease course: A US population-based cohort

  Radwan, Y. A., Kurmann, R. D., Sandhu, A. S., El-Am, E. A., Crowson, C. S., Matteson, E. L., Osborn, T. G., Warrington, K. J., Mankad, R. & Makol, A., 2021, In: Journal of Scleroderma and Related Disorders. 6, 3, p. 277-285 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Systemic Scleroderma 100%
  • Sclerosis 66%
  • Population 34%
  • Confidence Intervals 31%
  • Electrocardiography 21%
• 2020

  British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis

  MacKie, S. L., Dejaco, C., Appenzeller, S., Camellino, D., Duftner, C., Gonzalez-Chiappe, S., Mahr, A., Mukhtyar, C., Reynolds, G., De Souza, A. W. S., Brouwer, E., Bukhari, M., Buttgereit, F., Byrne, D., Cid, M. C., Cimmino, M., Direskeneli, H., Gilbert, K., Kermani, T. A., Khan, A., & 16 othersLanyon, P., Luqmani, R., Mallen, C., Mason, J. C., Matteson, E. L., Merkel, P. A., Mollan, S., Neill, L., Sullivan, E. O., Sandovici, M., Schmidt, W. A., Watts, R., Whitlock, M., Yacyshyn, E., Ytterberg, S. & Dasgupta, B., Mar 1 2020, In: Rheumatology (United Kingdom). 59, 3, p. E1-E23

  Research output: Contribution to journal › Article › peer-review

  Open Access
  31 Scopus citations

• British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: Executive summary

  MacKie, S. L., Dejaco, C., Appenzeller, S., Camellino, D., Duftner, C., Gonzalez-Chiappe, S., Mahr, A., Mukhtyar, C., Reynolds, G., De Souza, A. W. S., Brouwer, E., Bukhari, M., Buttgereit, F., Byrne, D., Cid, M. C., Cimmino, M., Direskeneli, H., Gilbert, K., Kermani, T. A., Khan, A., & 16 othersLanyon, P., Luqmani, R., Mallen, C., Mason, J. C., Matteson, E. L., Merkel, P. A., Mollan, S., Neill, L., Sullivan, E. O., Sandovici, M., Schmidt, W. A., Watts, R., Whitlock, M., Yacyshyn, E., Ytterberg, S. & Dasgupta, B., Mar 1 2020, In: Rheumatology (United Kingdom). 59, 3, p. 487-494 8 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access
  20 Scopus citations

• Cardiovascular Risk Factors and Atherosclerotic Cardiovascular Events Among Incident Cases of Systemic Sclerosis: Results From a Population-Based Cohort (1980-2016)

  Kurmann, R. D., Sandhu, A. S., Crowson, C. S., Matteson, E. L., Osborn, T. G., Warrington, K. J., Mankad, R. & Makol, A., Jul 2020, In: Mayo Clinic proceedings. 95, 7, p. 1369-1378 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Systemic Scleroderma 100%
  • Population 34%
  • Sclerosis 15%
  • American Heart Association 14%
  • Cardiology 14%
  1 Scopus citations

• Changes in the Presentation of Incident Gout and the Risk of Subsequent Flares: A Population-based Study over 20 Years

  Elfishawi, M. M., Zleik, N., Kvrgic, Z., Michet, C. J., Crowson, C. S., Matteson, E. L. & Bongartz, T., Apr 1 2020, In: Journal of Rheumatology. 47, 4, p. 613-618 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Gout 100%
  • Population 32%
  • Hyperuricemia 20%
  • Kidney Diseases 17%
  • Frailty 9%
  4 Scopus citations

• Comparison of biopsy-proven giant cell arteritis in North America and Southern Europe: a population-based study

  Muratore, F., Crowson, C. S., Boiardi, L., Pinelli, A., Koster, M. J., Restuccia, G., Kermani, T. A., Matteson, E. L., Salvarani, C. & Warrington, K. J., Mar 1 2020, In: Clinical and experimental rheumatology. 38, 2, p. 79-83 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Giant Cell Arteritis 100%
  • North America 82%
  • Biopsy 46%
  • Population 30%
  • Glucocorticoids 23%
  1 Scopus citations

• Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire

  Myasoedova, E., De Thurah, A., Erpelding, M. L., Schneeberger, E. E., Maribo, T., Citera, G., Davis, J. M., Matteson, E. L., Crowson, C. S., Fautrel, B. & Guillemin, F., Apr 2020, In: Seminars in Arthritis and Rheumatism. 50, 2, p. 261-265 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Rheumatoid Arthritis 100%
  • RA 25 27%
  • Area Under Curve 21%
  • Argentina 16%
  • Rheumatology 14%
  2 Scopus citations

• Distinct Single Cell Gene Expression in Peripheral Blood Monocytes Correlates With Tumor Necrosis Factor Inhibitor Treatment Response Groups Defined by Type I Interferon in Rheumatoid Arthritis

  Wampler Muskardin, T. L., Fan, W., Jin, Z., Jensen, M. A., Dorschner, J. M., Ghodke-Puranik, Y., Dicke, B., Vsetecka, D., Wright, K., Mason, T., Persellin, S., Michet, C. J., Davis, J. M., Matteson, E. & Niewold, T. B., Jul 16 2020, In: Frontiers in immunology. 11, 1384.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Interferon Type I 98%
  • Monocytes 68%
  • Rheumatoid Arthritis 68%
  • Gene Expression 49%
  • Biological Products 23%

• Efficacy and Safety of Tofacitinib, Baricitinib, and Upadacitinib for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

  Wang, F., Sun, L., Wang, S., Davis, J. M., Matteson, E. L., Murad, M. H., Luo, F. & Vassallo, R., Jul 2020, In: Mayo Clinic proceedings. 95, 7, p. 1404-1419 16 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • upadacitinib 100%
  • baricitinib 92%
  • tofacitinib 78%
  • Rheumatoid Arthritis 41%
  • Meta-Analysis 37%
  7 Scopus citations

• Increased hospitalization rates following heart failure diagnosis in rheumatoid arthritis as compared to the general population

  Myasoedova, E., Davis, J. M., Matteson, E. L., Achenbach, S. J., Setoguchi, S., Dunlay, S. M., Roger, V. L., Gabriel, S. E. & Crowson, C. S., Feb 2020, In: Seminars in Arthritis and Rheumatism. 50, 1, p. 25-29 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Rheumatoid Arthritis 100%
  • Hospitalization 89%
  • Heart Failure 88%
  • Population 47%
  • Arthritis 42%
  1 Scopus citations

• Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985-2014

  Myasoedova, E., Davis, J., Matteson, E. L. & Crowson, C. S., Apr 1 2020, In: Annals of the rheumatic diseases. 79, 4, p. 440-444 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • White 100%
  • Rheumatoid Arthritis 98%
  • Epidemiology 93%
  • Cohort Studies 81%
  • Rheumatoid Factor 69%
  22 Scopus citations

• Longitudinal Occurrence and Predictors of Patient-Provider Discordance Between Global Assessments of Disease Activity in Rheumatoid Arthritis: A Case–Control Study

  Challa, D. N. V., Kvrgic, Z., Crowson, C. S., Matteson, E. L., Mason, T. G., Michet, C. J., Schaffer, D. E., Wright, K. A. & Davis, J. M., Jan 1 2020, In: Arthritis Care and Research. 72, 1, p. 18-26 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Rheumatoid Arthritis 100%
  • Antinuclear Antibodies 31%
  • Logistic Models 17%
  • Fibromyalgia 15%
  • Antidepressive Agents 12%

• Longitudinal relationships between rheumatoid factor and cytokine expression by immunostimulated peripheral blood lymphocytes from patients with rheumatoid arthritis: New insights into B-cell activation

  Davis, J. M., Crowson, C. S., Knutson, K. L., Achenbach, S. J., Strausbauch, M. A., Therneau, T. M., Matteson, E. L., Gabriel, S. E. & Wettstein, P. J., Feb 2020, In: Clinical Immunology. 211, 108342.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Rheumatoid Factor 100%
  • Rheumatoid Arthritis 71%
  • B-Lymphocytes 66%
  • Lymphocytes 59%
  • Cytokines 53%
  3 Scopus citations

• Morbidity and Mortality of Large-Vessel Vasculitides

  Koster, M. J., Warrington, K. J. & Matteson, E. L., Dec 1 2020, In: Current rheumatology reports. 22, 12, 86.

  Research output: Contribution to journal › Review article › peer-review

  • Giant Cell Arteritis 100%
  • Takayasu Arteritis 85%
  • Vasculitis 79%
  • Morbidity 45%
  • Mortality 38%
  1 Scopus citations

• Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis

  Wadström, K., Jacobsson, L., Mohammad, A. J., Warrington, K. J., Matteson, E. L. & Turesson, C., Nov 1 2020, In: Rheumatology (United Kingdom). 59, 11, p. 3229-3236 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Giant Cell Arteritis 100%
  • Blood Glucose 63%
  • Triglycerides 61%
  • Fasting 61%
  • Cholesterol 56%
  5 Scopus citations

• Reply

  Duarte-García, A., Crowson, C. S., Warrington, K. J. & Matteson, E. L., Oct 1 2020, In: Arthritis and Rheumatology. 72, 10, p. 1776 1 p.

  Research output: Contribution to journal › Letter › peer-review
• 2019

  2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis

  Ehlers, L., Askling, J., Bijlsma, H. W. J., Cid, M. C., Cutolo, M., Dasgupta, B., Dejaco, C., Dixon, W. G., Feltelius, N., Finckh, A., Gilbert, K., Mackie, S. L., Mahr, A., Matteson, E. L., Neill, L., Salvarani, C., Schmidt, W. A., Strangfeld, A., Van Vollenhoven, R. F. & Buttgereit, F., Sep 1 2019, In: Annals of the rheumatic diseases. 78, 9, p. 1160-1166 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Giant Cell Arteritis 100%
  • Datasets 60%
  • Force 51%
  • Advisory Committees 27%
  • Epidemiologists 17%
  10 Scopus citations

• Association of smoking and obesity on the risk of developing primary Sjögren syndrome: A Population-based Cohort Study

  Servioli, L., Maciel, G., Nannini, C., Crowson, C. S., Matteson, E. L., Cornec, D. & Berti, A., 2019, In: Journal of Rheumatology. 46, 7, p. 727-730 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Smoking 100%
  • Obesity 96%
  • Cohort Studies 94%
  • Smokers 58%
  • Population 54%
  1 Scopus citations

• Clinical Characteristics of Ocular Sarcoidosis: A Population-Based Study 1976–2013

  Ungprasert, P., Tooley, A. A., Crowson, C. S., Matteson, E. L. & Smith, W. M., Apr 3 2019, In: Ocular Immunology and Inflammation. 27, 3, p. 389-395 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Sarcoidosis 100%
  • Uveitis 68%
  • Eye 56%
  • Scleritis 44%
  • Population 35%
  10 Scopus citations

• Comparison of Biologic Discontinuation in Patients With Elderly-Onset Versus Younger-Onset Rheumatoid Arthritis

  Richter, M. D., Matteson, E. L., Davis, J. M., Achenbach, S. J. & Crowson, C. S., Dec 1 2019, In: ACR Open Rheumatology. 1, 10, p. 627-631 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Rheumatoid Arthritis 100%
  • Elderly 81%
  • Confidence Intervals 25%
  • Incidence 12%
  • Rheumatology 9%

• Depletion of activated macrophages with a folate receptor-beta-specific antibody improves symptoms in mouse models of rheumatoid arthritis

  Hu, Y., Wang, B., Shen, J., Low, S. A., Putt, K. S., Niessen, H. W. M., Matteson, E. L., Murphy, L., Ruppert, C., Jansen, G., Oliver, S. J., Feng, Y., Dimitrov, D. S., Nickerson-Nutter, C. & Low, P. S., Jun 7 2019, In: Arthritis Research and Therapy. 21, 1, 143.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Folate Receptor 2 100%
  • Rheumatoid Arthritis 44%
  • Macrophages 38%
  • Antibodies 30%
  • Monoclonal Antibodies 17%
  11 Scopus citations

• Evidence of Diagnostic and Treatment Delay in Seronegative Rheumatoid Arthritis: Missing the Window of Opportunity

  Coffey, C. M., Crowson, C. S., Myasoedova, E., Matteson, E. L. & Davis, J. M., Nov 2019, In: Mayo Clinic proceedings. 94, 11, p. 2241-2248 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Time-to-Treatment 100%
  • Rheumatoid Arthritis 74%
  • Joints 38%
  • Antirheumatic Agents 32%
  • Rheumatoid Factor 21%
  6 Scopus citations